Related Experiment Videos

[Long-term results of the Blalock-Taussig shunts]

N Yoshimura1, M Yamaguchi, H Ohashi

  • 1Department of Cardio-Thoracic Surgery, Kobe Children's Hospital, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|September 1, 1992
PubMed

Insights

The classical Blalock-Taussig shunt demonstrated a low operative mortality of 0.7% in 136 patients. Polydioxanone suture (PDS) may enhance anastomotic growth in Blalock-Taussig operations.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Disease
  • Surgical Techniques

Context:

  • The Blalock-Taussig shunt is a palliative procedure for cyanotic congenital heart disease.
  • Between 1980 and 1990, 136 patients underwent classical Blalock-Taussig shunts.
  • Patient ages ranged from 4 days to 12.8 years, with a median of 13 months.

Purpose:

  • To evaluate the outcomes and long-term efficacy of the classical Blalock-Taussig shunt.
  • To assess the need for re-interventions and corrective surgeries post-shunt.
  • To investigate the potential benefits of polydioxanone suture (PDS) in Blalock-Taussig shunts.

Summary:

  • Operative mortality was 0.7%, with a 5.4-year average follow-up.
  • 91.0% and 76.4% of patients remained well-palliated at 1 and 3 years post-operation, respectively.
  • Vascular anastomotic stenosis occurred in 49.3% of patients; PDS may improve anastomotic growth.

Impact:

  • The classical Blalock-Taussig shunt offers a low-risk palliative option for complex congenital heart defects.
  • Further research into PDS use could optimize shunt longevity and reduce re-intervention rates.
  • This study provides valuable long-term data on shunt patency and patient outcomes.

Related Concept Videos